r The expression of AT 1 R b mRNA is ß30-fold higher than AT 1 R a in whole cerebral arteries and ß45-fold higher in isolated cerebral artery smooth muscle cells. Abstract Myogenic vasoconstriction, which reflects the intrinsic ability of smooth muscle cells to contract in response to increases in intraluminal pressure, is critically important for the autoregulation of blood flow. In smooth muscle cells from cerebral arteries, increasing intraluminal pressure engages a signalling cascade that stimulates cation influx through transient receptor potential (TRP) melastatin 4 (TRPM4) channels to cause membrane depolarization and vasoconstriction. Substantial evidence indicates that the angiotensin II receptor type 1 (AT 1 R) is inherently mechanosensitive and initiates this signalling pathway. Rodents express two types of AT 1 R -AT 1 R a and AT 1 R b -and conflicting studies provide support for either isoform as the primary sensor of intraluminal pressure in peripheral arteries. We hypothesized that mechanical activation of AT 1 R a increases TRPM4 currents to induce myogenic constriction of cerebral arteries. However, we found that development of myogenic tone was greater in arteries from AT 1 R a knockout animals compared with controls. In patch-clamp experiments using native cerebral arterial myocytes, membrane stretch-induced cation currents were blocked by the TRPM4 inhibitor 9-phenanthrol in both groups. Further, the AT 1 R blocker losartan (1 μM) diminished myogenic tone and blocked stretch-induced cation currents in cerebral arteries from both groups. Activation of AT 1 R with angiotensin II (30 nM) also increased TRPM4 currents in smooth muscle cells and constricted cerebral arteries from both groups. Expression of AT 1 R b mRNA was ß30-fold greater than AT 1 R a in cerebral arteries, and knockdown of AT 1 R b selectively diminished myogenic constriction. We conclude that AT 1 R b , acting upstream of TRPM4 channels, is the primary sensor of intraluminal pressure in cerebral artery smooth muscle cells. * P. W. Pires, E.-A. Ko and H. A. T. Pritchard contributed equally to this work.
Introduction
Arterial constriction in response to increases in intraluminal pressure, often referred to as the vascular myogenic response, reflects the intrinsic ability of vascular smooth muscle cells to contract in response to mechanical stress (Davis & Hill, 1999) . This capability is largely responsible for maintaining blood flow at relatively constant levels during fluctuations in systemic arterial pressure. Although pressure-induced vasoconstriction occurs in most segments of the resistance vasculature, autoregulation of the cerebral circulation is particularly important for sustaining near-constant global blood flow to the brain. Unfettered drops in perfusion of the brain can lead to loss of consciousness or primary ischaemia, and exposure of the cerebral microcirculation to unregulated increases in perfusion can cause vasogenic oedema and hyperperfusion-induced encephalopathy (Rosenberg, 1999) . Many cardiovascular diseases are associated with disrupted myogenic responsiveness and autoregulation, including ischaemic stroke, hypertension, and diabetes mellitus (Zimmermann et al. 1997; Cipolla & Curry, 2002; Pires et al. 2015) . Despite the importance of this response, the molecular mechanisms responsible for sensing changes in intraluminal pressure remain incompletely understood.
Prior studies conducted over several decades have demonstrated that increases in intraluminal pressure lead to vascular smooth muscle cell membrane depolarization, Ca 2+ influx through voltage-dependent Ca V 1.2 channels, and arterial constriction (Harder, 1984) . Upstream mechanisms that initiate pressure-induced membrane depolarization were revealed by a recent study from our laboratory, which showed that membrane stretch activates a phospholipase (PLC) γ1-dependent signalling cascade, leading to generation of intracellular inositol triphosphate (IP 3 ) and diacylglycerol (DAG). These potent second messengers cause activation of the transient receptor potential (TRP) cation channels, TRPC6 (via DAG) and TRPM4 (via Ca 2+ released from the sarcoplasmic reticulum (SR) through IP 3 receptors), resulting in depolarization of the arterial sarcolemma (Gonzales et al. 2014) . It is unlikely that TRPM4 channels inherently sense intraluminal pressure because these channels are not directly activated by stretch of the plasma membrane (Gonzales et al. 2014) , whereas the intrinsic mechanical sensitivity of TRPC6 channels is a matter of debate (Spassova et al. 2006; Mederos y Schnitzler et al. 2008) . The surprising discovery that previously characterized heterotrimeric G-protein-coupled receptors (GPCRs) are inherently mechanosensitive has stimulated investigation of these membrane proteins as upstream mediators of stretch-and pressure-activated responses (Rakesh et al. 2010; Scimia et al. 2012; Storch et al. 2012) .
The angiotensin II type 1 receptor (AT 1 R) is a broadly distributed GPCR that is important for numerous physiological processes regulated by the renin-angiotensin system (Kambayashi et al. 1993) . AT 1 R-dependent signalling pathways are activated by mechanical stretch in a manner that is independent of angiotensin II (Ang II) binding, indicating that the receptor is inherently mechanosensitive (Zou et al. 2004) . Humans express a single type of AT 1 R, whereas two nearly identical isoforms (AT 1 R a and AT 1 R b ) are present in rodents (Madhun et al. 1993; Zhou et al. 1993; Tian et al. 1996) . Conflicting studies have used genetic knockout mice to support claims that either AT 1 R a (Schleifenbaum et al. 2014) or AT 1 R b (Blodow et al. 2014 ) is primarily responsible for detecting changes in vascular pressure. Resolution of this question is important for interpreting prior studies using isoform-specific AT 1 R-knockout mice and designing future experiments to better understand the impact of agonist-dependent vs. mechanically induced AT 1 R signalling during vascular disease. Our findings show that the AT 1 R b isoform is the primary sensor of membrane stretch and intraluminal pressure in cerebral artery myocytes, and that myogenic vasoconstriction of cerebral and mesenteric arteries is independent of AT 1 R a expression. TRPM4-dependent cation currents are induced by activation of AT 1 R by mechanical stretch as well as Ang II, suggesting that these stimuli could act in an additive or synergistic manner under physiological conditions.
Methods

Animals and isolation of cerebral arteries and smooth muscle cells
Young adult (8-10 weeks) WT C57BL/6J mice (Jackson Laboratories Bar Harbor, ME, USA) and homozygous AT 1 R a −/− (B6.129P2-Agtr1 tm1Unc /J, Jackson Laboratories) mice were used for these studies. Animals were maintained Native smooth muscle cells for patch-clamp experiments were obtained by initially digesting isolated arteries in papain (1 mg ml −1 ; Worthington Biochemical Corporation, Lakewood, NJ, USA), dithiothreitol (1 mg ml −1 ) and BSA (1 mg ml −1 ) in Ca 2+ -free PSS at 37°C for 12 min, followed by a 14 min incubation with type II collagenase (1 mg ml −1 , Worthington Biochemical Corporation). The digested arteries were washed three times with Ca 2+ -free PSS and triturated with a polished glass pipette to dissociate single smooth muscle cells. All cells used in the study were freshly dissociated on the day of experiments.
Electrophysiological recording
Transient inward cation currents (TICCs) resulting from the endogenous activity of TRPM4 channels were recorded using the amphotericin D (200 μg ml −1 ) perforated-patch configuration at a holding membrane potential of −70 mV. TICCs were recorded in a bath solution consisting of 134 mM NaCl, 6 mM KCl, 1 mM MgCl 2 , 10 mM glucose, 10 mM Hepes and 1.8 mM CaCl 2 , pH 7.4. The pipette solution was composed of 110 mM potassium aspartate, 10 mM NaCl, 30 mM KCl, 1 mM MgCl 2 , 5 mM Hepes and 0.005 mM EGTA, pH 7.2. Patch pipettes (3-4 M ) were fabricated on a model P-87 micropipette puller (Sutter Instruments, Novado, CA, USA) and polished with a MF-830 MicroForge (Narishige Scientific Instruments Laboratories, Long Island, NY, USA). Perforated-patch whole-cell currents were recorded using an Axopatch-200B amplifier (Molecular Devices, Sunnyvale, CA, USA) and a Digidata 1440A digitizer (Molecular Devices). Membrane stretch was delivered by applying negative pressure through the recording electrode using a Clampex controlled pressure clamp HSPC-1 device (ALA Scientific Instruments Inc., Farmingdale, NY, USA). Stretch-activated TICCs were recorded at a holding potential of −70 mV with -20 mmHg of pressure applied to the membrane. The open channel probability (NP o ) of TICCs was calculated as the sum of multiple open states of 1.75 pA (Gonzales et al. 2010a) .
RNA isolation and endpoint RT-PCR
Total RNA was isolated from mouse cerebral arteries using an RNeasy Mini Kit (Qiagen, Valencia, CA, USA). cDNA was synthesized from total RNA using qScript cDNA SuperMix (Quanta Biosciences Inc., Gaithersburg, MD, USA). Endpoint PCR was performed on a T100 Thermal Cycler (Bio-Rad, Hercules, CA, USA) using previously described AT 1 R a and AT 1 R b primers and cycling conditions (Daugherty et al. 2004) . The primer sequences for AT 1 R a and AT 1 R b endpoint RT-PCR are presented in Table 1 . PCR products were resolved by agarose gel electrophoresis using 2% gels and visualized with ethidium bromide. A no-template negative control reaction was included for all PCR experiments.
Fluorescence-activated cell sorting (FACS) flow cytometry
Native cerebral artery smooth muscle cells were isolated from transgenic reporter mice expressing enhanced green J Physiol 595.14 fluorescence protein (eGFP) under the control of the myosin heavy chain promoter (smMHC Cre/eGFP ) that directs eGFP expression exclusively in smooth muscle cells (Xin et al. 2002 ) using a protocol developed by colleagues at our institution (Lee et al. 2014) . Cerebral arteries from smMHC Cre/eGFP mice were enzymatically dispersed as described and eGFP expressing cells were sorted by FACS using a BD Biosciences FACSAria II Special Order Research Product (San Jose, CA, USA) with a 130 μm nozzle at a sheath pressure of 12 lbf in −2 . Cell viability was assessed with Hoechst 33 258 (1 μg ml −1 ) using a 355 nm UV laser excitation and emission detection using a 450/50 nm bandpass filter. Cells with compromised membranes (positively stained with Hoechst 33258) were eliminated. A total of 250 000 events per experiment were analysed, and cells that were negative for Hoechst 33258 but positive for eGFP (488 nm excitation, defined as a minimum of 10 3 fluorescence emission) were collected into a 12 × 75 mm tube containing PBS and 1% fetal bovine serum and further processed for mRNA isolation. 15 000-20 000 smooth muscle cells per replicate experiment were collected using this protocol. Efficiency of isolation was verified by qRT-PCR assay for the endothelial cell markers endothelial nitric oxide synthase (eNOS) and platelet endothelial cell adhesion molecule 1 (PECAM1), which were essentially undetectable in mRNA isolated from FACS-purified SMC. FACS was performed in the FACS / FCMSRL Core Facility at the University of Nevada, Reno School of Medicine.
Quantitative PCR
The relative abundance of AT 1 R a and AT 1 R b mRNA isoforms in mouse cerebral arteries, mesenteric arteries and kidneys was determined by quantitative RT-PCR (RT-qPCR). cDNA was synthesized from total RNA using an RNeasy Mini Kit (Qiagen GmbH, Hilden, Germany), following the manufacturer's instructions. qPCR analyses of AT 1 R a and AT 1 R b mRNAs were performed using Fast SYBR Green Master Mix (Applied Biosystems, Foster City, CA, USA) with the CFX Connect Real-Time System (Bio-Rad). Sequences of AT 1 R a and AT 1 R b primers used for qPCR are presented in Table 1 . β-Actin (ActB, Mm Actb 1 SG QuantiTect Primer Assay; Qiagen) was used as a normalization control for AT 1 R a and AT 1 R b . Reactions, performed in triplicate, contained 10 μl SYBR Green Master Mix, 1 μl of 250 nM forward and reverse primers, 1 μl of cDNA (normalized to 20 ng of RNA) and 8 μl of molecular biology grade water. The cycling conditions for PCR reactions were 95°C for 3 min, followed by 40 cycles of 95°C for 30 s and 60°C for 30 s, and then 1 cycle of 95°C for 1 min and 1 cycle of 55°C for 1 min. Amplification data were collected during each of the 40 cycles. At the end of the cycling programme, a DNA melting curve analysis was performed to confirm that a single product was amplified. No-template control reactions were included in every run to monitor for contamination. Cycle thresholds (C t ) for the genes of interest were recorded using Bio-Rad CFX Manager 3.0 (Bio-Rad) software in the single-threshold mode.
Pressure myography
Myogenic constriction of posterior cerebral arteries from WT and AT 1 R a −/− mice in response to acute increases in intraluminal pressure was studied in cannulated artery segments. Briefly, arteries were mounted between two glass pipettes (outer diameter, 40-50 μm) in a pressure myograph chamber (Living Systems Instrumentation, Burlington, VT, USA) and secured with a nylon thread. For visualization of pressurized vessels, the chamber was transferred to an inverted microscope (Accu-Scope Inc., Commack, NY, USA) coupled to a USB video camera (The Imaging Source LLC, Charlotte, NC, USA) controlled by IonWizard software (version 6.4.1.73; IonOptix LLC, Westwood, MA, USA). Arteries were bathed in PSS consisting of 119 mM NaCl, 4.7 mM KCl, 24 mM NaHCO 3 , 1.2 mM MgSO 4 , 1.8 mM CaCl 2 , 0.2 mM KH 2 PO 4 , 5 mM glucose, and were allowed to equilibrate in warm (37°C), oxygenated (21% O 2 , 6% CO 2 , 73% N 2 ) PSS at an intraluminal pressure of 20 mmHg for 15 min. Arterial viability was verified by measuring depolarization and constriction in response to bath application of high extracellular [K + ] PSS (60 mM KCl, 63.7 mM NaCl). Arteries that showed less than 5% constriction to KCl were discarded. Intraluminal pressure was then raised to 50 mmHg, and the vessel was allowed to develop spontaneous myogenic tone before conducting experiments. Outer and luminal diameters were constantly recorded using IonWizard software.
Assessment of myogenic reactivity and passive structure
Pressurized cerebral and mesenteric arteries were bathed in Ca 2+ -containing PSS, then intraluminal pressure was raised from 5 mmHg to 140 mmHg in 20 mmHg increments. Vessels were allowed to equilibrate for at least 7 min at each pressure or until a steady-state diameter was achieved. In some arteries, the AT 1 R-selective antagonist losartan (1 μM) was added to the superfusing bath solution to block AT 1 R responses. Intraluminal pressure was reset to 50 mmHg, and passive diameter was recorded after washing arteries with Ca 2+ -free PSS supplemented with EGTA (2 mM) and diltiazem (10 μM) to inhibit voltage-dependent Ca V 1.2 channels. Intraluminal pressure was raised from 5 mmHg to 140 mmHg in 20 mmHg increments, and passive outer and lumen diameter were recorded at each pressure step. Myogenic tone at each pressure was calculated as percentage myogenic tone = [1 -(active lumen diameter/passive lumen diameter)] × 100, as previously described (Pires et al. 2015) .
Assessment of depolarization and agonist-induced vasoconstriction
To determine whether changes in myogenic reactivity were caused by a general impairment in contractility, we assessed the ability of cerebral arteries from WT and AT 1 R a −/− mice to constrict after incubation with 60 mM [K + ] PSS, ET-1, or Ang II. Vessels were equilibrated at 50 mmHg intraluminal pressure and exposed to elevated [K + ] (60 mM). After washing out the KCl, arteries were incubated in increasing concentrations of ET-1 (0.1 pM to 100 nM) or a single dose of Ang II (30 nM). For ET-1 experiments, steady-state constriction was achieved by allowing arteries to equilibrate for ß5 min at each ET-1 concentration before the next concentration was added to the superfusing bath. In all experiments, outer and lumen diameters were constantly recorded; passive diameter was recorded at the end of each experiment by incubating vessels in Ca 2+ -free PSS supplemented with EGTA (2 mM) and diltiazem (10 μM). Constriction data are expressed as percentage vasoconstriction, calculated as percentage vasoconstriction = [(lumen diameter at constriction -lumen diameter at baseline)/passive lumen diameter] × 100.
AT 1 R b knockdown with morpholino oligonucleotides
Morpholino oligonucleotides (morpholinos), providing target-specific protein knockdown through steric inhibition of mRNA translation, were used to knock down AT 1 R b in intact cerebral arteries from WT and AT 1 R a −/− mice, as described previously (Jepps et al. 2014 (Jepps et al. , 2015 . Briefly, a 25-base AT 1 R b morpholino designed to block part of the 5 -untranslated region, the start codon, and several coding bases of the AT 1 R b mRNA was synthesized by Gene Tools, LLC (Philomath, OR, USA). A non-silencing morpholino (Gene Tools, LLC) with no known binding targets in rodents was used as control for all experiments. A fluorescent control morpholino, created by adding Lissamine to the 3 -end of a standard control morpholino, was used in some experiments. The nucleotide sequences of the morpholinos used in this study are presented in Table 1 .
For delivery of morpholinos to arterial myocytes in intact cerebral arteries, a 50 μM solution of morpholinos in Opti-MEM (Thermo Fisher Scientific, Waltham, MA, USA) was mixed with an equal volume of a 0.017 mg ml −1 solution of Lipofectamine 2000 (Thermo Fisher Scientific) in Opti-MEM, and incubated for 2 h at room temperature. This solution was then combined with 1 ml of serum-free Dulbecco's modified Eagle's medium (Thermo Fisher Scientific) containing penicillin-streptomycin (1%), after which isolated cerebral arteries were immersed in the morpholino-containing solution and incubated for 36 h at 37°in a humidified 5% CO 2 environment. Uptake of morpholinos into cerebral arterial smooth muscle cells was verified by visualizing isolated smooth muscle cells transfected with Lissamine-tagged control morpholinos and stained with a plasma membrane-specific dye (CellMask Green Plasma Membrane Stain; Thermo Fisher Scientific, Eugene, OR, USA). Fluorescence images were acquired using an Olympus IX81 FV1000D Spectral Type laser scanning confocal microscope and a 60×, 1.42 numerical aperture oil-immersion objective, with the pinhole diameter automatically set to 1 Airy Unit. All imaging parameters (laser power, gain and offset) were established using cells treated with Lissamine-tagged control morpholinos, and the same parameters were used to image subsequent cells incubated with Lissamine-tagged and non-tagged standard control morpholinos.
Chemicals
Unless otherwise stated, all chemical supplies were purchased from Sigma-Aldrich (St Louis, MO, USA).
Statistical analysis
All summary data are expressed as means ± SEM. Statistical analyses were performed and graphs were constructed using Prism 6.0 (GraphPad Software, Inc., La Jolla, CA, USA). The significance of differences in myogenic reactivity, endothelin-1 (ET-1)-dependent constriction, and pressure-dependent changes in transient inward cation current (TICC) activity among groups was analysed by two-way analysis of variance (ANOVA AT 1 R a knockout in cerebral arteries from AT 1 R a −/− mice was confirmed by reverse transcription-polymerase chain reaction (RT-PCR) analysis. As expected, mRNAs encoding AT 1 R a and AT 1 R b were present in cerebral arteries from WT mice, whereas only AT 1 R b mRNA was detected in cerebral arteries from AT 1 R a −/− mice (Fig. 1A) . Pressure myography, used to examine J Physiol 595.14 contractile responses in cerebral arteries obtained from WT and AT 1 R a −/− mice, revealed no differences in vasoconstriction in response to elevated extracellular [K + ] (60 mM) or increasing concentrations of the GPCR agonist endothelin-1 (ET-1) between genotypes (logEC 50 for ET-1 = −8.4 ± 0.3 and −9.2 ± 0.5 for WT and AT 1 R a −/− , respectively; n = 4 arteries per group; Fig. 1B  and C) . Myogenic tone was assessed by increasing intraluminal pressure in 20 mmHg increments and allowing the ensuing constrictor response to reach steady state. Passive vessel diameter was determined by repeating this procedure following removal of extracellular Ca 2+ , and active myogenic tone was calculated and normalized to the passive response. Surprisingly, we found that myogenic tone was significantly greater in cerebral arteries from AT 1 R a −/− mice than in those from WT mice (Fig. 1D) . showing that mRNAs encoding AT 1 R a and AT 1 R b are present in cerebral arteries from WT mice, whereas mRNA encoding AT 1 R a is not detected in cerebral arteries from AT 1 R a −/− mice. NTC, no template control. B, summary data showing that vasoconstriction in response to elevated extracellular levels of KCl (60 mM) does not differ between cerebral arteries from WT and AT 1 R a −/− mice (n = 13 for WT and AT 1 R a −/− ). C, representative traces (left) and summary data (right) showing that vasoconstriction in response to the GPCR agonist ET-1 does not differ between cerebral arteries from WT and AT 1 R a −/− mice (n = 4 arteries per group). D, representative traces (left) and summary data (right) showing that the development of myogenic tone in response to increases in intraluminal pressure is greater in cerebral arteries from AT 1 R a −/− mice (n = 6 arteries) than in WT mice (n = 5 arteries; * P < 0.05).
These data contrast with recent findings (Schleifenbaum et al. 2014) showing an obligate role for AT 1 R a expression in the development of myogenic tone of mesenteric and renal resistance arteries. To determine if this discrepancy was due to differences in pressure-sensing mechanisms among vascular beds, we compared myogenic tone in third-order mesenteric resistance arteries from WT and AT 1 R a −/− mice and found no differences (Fig. 2) . Further, AT1R a knockout did not promote gross alterations in the passive diameters and wall thickness of either cerebral arteries or third-order mesenteric arteries (Fig. 3) , showing that the differences in myogenic responses are due to altered contractility and independent of structural changes in the pressure-diameter relationship of the studied arteries. We conclude that expression of AT 1 R a is not required for myogenic vasoconstriction of cerebral or mesenteric arteries.
Stretch-induced activation of cation currents in smooth muscle cells is not altered by AT 1 R a deletion
Cation currents conducted by TRPM4 channels are a major pressure-induced depolarizing influence in cerebral artery smooth muscle cells (Earley et al. 2004 (Earley et al. , 2007 Gonzales et al. 2010b) . Using the perforated patch-clamp configuration, important to prevent dialysis of the cytoplasmic content and disruption of intracellular Ca 2+ signalling pathways (Gonzales et al. 2010a), TRPM4 currents are recorded from native smooth muscle cells as transient inward cation currents (TICCs). Using this approach, we measured currents activated by plasma membrane stretch caused by applying negative pressure to the patch pipette. Basal TICC activity (patch pipette pressure, −3 mmHg) did not differ between smooth muscle cells isolated from WT and AT 1 R a −/− mice (Fig. 4A) . In both groups, TICC activity was increased by application of additional pipette suction, and these stretch-induced currents were inhibited by the TRPM4 blocking compound 9-phenanthrol (Fig. 4A ). Increases in current density in response to negative pressure did not differ between smooth muscle cells from WT and AT 1 R a mice (Fig. 4B) .
Losartan inhibits myogenic responses in cerebral arteries
Our data indicate that AT 1 R a expression is not required for myogenic constriction of cerebral arteries or stretch-induced increases in cation currents in smooth muscle cells. To determine if AT 1 R b could be involved in these responses, we tested the effects of the selective AT 1 R antagonist losartan. Losartan (1 μM) blunted the development of myogenic tone in cerebral arteries from WT mice (Fig. 5A) and AT 1 R a −/− mice (Fig. 5B) . In patch-clamp experiments, losartan (1 μM) inhibited TICCs elicited by the application of negative pressure J Physiol 595.14 (−20 mmHg) to the patch pipette in smooth muscle cells from WT and AT 1 R a −/− mice (Fig. 6A ). However, losartan had no effect on TRPM4-dependent cation currents evoked by administration of the purinergic GPCR agonist UTP (Fig. 6B) , indicating that losartan specifically blocks stretch-induced activation of these currents and has no direct effect on channel activity. In control experiments, we exposed another set of cells to UTP and found that that 9-phenanthrol largely blocked the resulting TICC activity (Fig. 6B) , indicating a significant TRPM4 component. These data demonstrate that TRPM4 cation currents are induced by application of mechanical stress to the plasma membrane and that this response is independent of AT 1 R a expression. Together, these findings indicate that a losartan-sensitive receptor other than AT 1 R a is necessary for myogenic constriction and activation of stretch-induced cation currents in cerebral artery smooth muscle cells.
AT 1 R b expression is necessary for the development of myogenic tone
The obvious non-AT 1 R a candidate for primary initiator of myogenic constriction in cerebral artery smooth muscle cells is the AT 1 R b receptor. To test whether this is indeed the case, we used a recently developed approach employing targeted silencing morpholinos (Jepps et al. 2014 (Jepps et al. , 2015 −/− mice A, lumen diameter, outer diameter and wall thickness of cerebral arteries were not different between WT and AT 1 R a −/− mice (n = 11 arteries per group). B, no differences in lumen and outer diameters or wall thickness were observed in third-order mesenteric arteries between WT and AT 1 R a −/− mice (n = 5 arteries per group). Passive diameters were assessed by bathing the arteries in Ca 2+ -free PSS supplemented with EGTA (2 mM) and the Ca V 1.2 channel inhibitor diltiazem (10 µM) to assure maximal dilatation at each intraluminal pressure.
in smooth muscle cells in cerebral arteries from WT mice. Initial experiments using control morpholinos containing a 3 Lissamine tag were performed to validate delivery to cerebral myocytes in intact vessels. Confocal microscopy imaging revealed the presence of fluorescent morpholinos in enzymatically dispersed smooth muscle cells obtained from arteries transfected with Lissamine-tagged morpholinos (Fig. 7A, left) , whereas no fluorescence was detected in smooth muscle cells isolated from arteries incubated with non-tagged, standard control morpholinos (Fig. 7A, right ). These data demonstrate that morpholinos can be efficiently delivered to smooth muscle cells in cerebral resistance vessels. Demonstration of knockdown at the molecular level is not A, representative traces from perforated patch-clamp experiments demonstrating that increasing negative pressure on the patch pipette from −3 to −20 mmHg increases TICC activity in cerebral artery smooth muscle cells from WT and AT 1 R a −/− mice are shown on the left. These currents were nearly abolished by the TRPM4 blocker 9-phenanthrol (30 µM). The right panels show summary data (WT, n = 9-10 cells per group; AT 1 R a −/− , n = 5-7 cells per group); * P < 0.05. B, summary data demonstrating that increases in TICC NP o in response to increasing negative pressure applied to the patch pipette are not different between cerebral artery smooth muscle cells from WT (n = 9-11 cells per group) and AT 1 R a −/− (n = 7-16 cells per group) mice.
J Physiol 595.14 feasible, as the morpholino-based approach does not alter transcript levels in most cases and the available primary antibodies do not distinguish between the highly homologous AT 1 R a and AT 1 R b isoforms. The functional effects of AT 1 R b knockdown in cerebral arteries from WT mice were evaluated using pressure myography. Vasoconstriction in response to Ang II (30 nM) or elevated extracellular [K + ] (60 mM) did not differ between arteries treated with standard control or AT 1 R b -targeted morpholinos (Fig. 7B-D) . However, development of myogenic tone was nearly abolished in cerebral arteries incubated with morpholinos targeting AT 1 R b , whereas arteries treated with standard control morpholinos exhibited robust myogenic reactivity (Fig. 7E) . These data clearly indicate that AT 1 R b is specifically required for pressure-induced vasoconstriction of cerebral arteries.
The involvement of AT 1 R b in myogenic reactivity and constriction to Ang II was further assessed by knocking down AT 1 R b expression in cerebral arteries from AT 1 R a −/− mice. AT 1 R b knockdown nearly abolished vasoconstriction to Ang II (30 nM) in cerebral arteries isolated from AT 1 R a −/− mice ( Fig. 8A and B) , whereas constriction to elevated extracellular [K + ] (60 mM) did not differ between these groups (Fig. 8C) . Myogenic constriction was nearly abolished in cerebral arteries from AT 1 R a −/− after AT 1 R b knockdown ( Fig. 8D and E) . These data suggest that activation of either AT 1 R a or AT 1 R b with Ang II can cause cerebral artery constriction, but expression of AT 1 R b is obligatory for pressure-induced constriction.
AT 1 R b is expressed at higher levels than AT 1 R a in whole cerebral arteries and isolated cerebral artery myocytes
The amino acid sequences of AT 1 R a and AT 1 R b are nearly identical, differing at only 23 of 359 residues, and both are highly homologous to human AT 1 R. Thus, it is unlikely that divergence in the respective roles of AT 1 R a and AT 1 R b in the development of myogenic tone result from fundamental differences in structure between the two isoforms. A recent study by Blodow et al. (2014) attributed the differential roles of these receptor subtypes in the vasculature to elevated expression of AT 1 R b relative to AT 1 R a . Consistent with this, we found that AT 1 R b mRNA levels were more than 30-fold higher than those of AT 1 R a in cerebral arteries from WT animals (Fig. 9A ). This pattern was also present in isolated cerebral artery smooth cells, where AT 1 R b mRNA expression levels are approximately 45-fold greater than mRNA levels for AT 1 R a (Fig. 9B) . AT 1 R b expression was also greater than AT 1 R a expression 
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−/− , n = 6-7 arteries per group). C, summary data showing that vasoconstriction of cerebral arteries from AT 1 R a −/− mice in response to elevated extracellular levels of KCl (60 mM) is not altered by AT 1 R b knockdown (n = 6-7 arteries per group). D and E, representative recordings (D) and summary data (E) demonstrating that myogenic constriction of cerebral arteries from AT 1 R a −/− mice is nearly abolished by AT 1 R b knockdown. ( * P < 0.05, n = 6-7 arteries per group).
J Physiol 595.14 in mesenteric arteries (Fig. 9C) , although the difference was smaller (ß2.4-fold). Control experiments employing mRNA from whole kidney indicated that the levels of AT 1 R a mRNA are ß7-times greater than those of AT 1 R b in this tissue (Fig. 9D) . These data suggest that differences in expression levels account for the lesser role of AT 1 R a in myogenic control of the cerebral vasculature.
Ang II stimulates TICC activity in cerebral artery smooth muscle cells
Ang II is a potent vasoconstrictor of cerebral arteries that acts through AT 1 R (Faraci et al. 2006) . Our data suggest that mechanical activation of AT 1 R b stimulates TRPM4-dependent cation currents in native smooth muscle cells and causes vasoconstriction of cerebral arteries, but whether mechanical-and agonist-dependent activation of AT 1 R link to the same downstream signalling pathways is unknown. Therefore, we used perforated patch-clamp electrophysiology to test the hypothesis that AT 1 R stimulation with Ang II induces TRPM4-dependent cation currents in cerebral artery myocytes. Ang II (30 nM) caused a marked increase in TICC activity in cerebral artery smooth muscle cells from WT mice, an effect that was blocked by the TRPM4 inhibitor 9-phenanthrol (Fig. 10A) . Ang II also stimulated TRPM4-dependent TICC activity in cells from AT 1 R a −/− mice (Fig. 10B ). In addition, administration of a single bolus of Ang II (30 nM) induced constriction of pressurized cerebral arteries from both WT and AT 1 R a −/− mice which was blocked by losartan (1 μM) (Fig. 10C) . These data suggest that activation of AT 1 R with Ang II stimulates TRPM4 activity in cerebral artery smooth muscle cells to cause vasoconstriction, and this response is at least partially independent of AT 1 R a activity.
Discussion
Smooth muscle cells within the walls of all arteries possess the intrinsic ability to contract in response to increased intraluminal pressure and relax in response to diminished pressure. This fundamental capacity establishes a direct relationship between arterial perfusion pressure and vascular resistance that serves to minimize variability in the rate of blood flow. Although this response was discovered more than 100 years ago (Bayliss, 1902) , the molecular mechanisms underlying it are not completely understood. In the present study, we used a combination of genetic and pharmacological approaches to examine the role of the G q -coupled receptor, AT 1 R, in sensing intraluminal pressure and stimulating increases in cation currents in native cerebral artery smooth muscle cells that . AT 1 R b mRNA is more abundant than AT 1 R a mRNA in cerebral and mesenteric arteries A, levels of AT 1 R b mRNA are ß30-fold greater than those of AT 1 R a in cerebral arteries from WT mice ( * P < 0.05; n = 5 separate experiments). B, mRNA expression of AT 1 R b is ß45-fold higher than that of AT 1 R a in isolated cerebral artery smooth muscle cells ( * P < 0.05; n = 3 separate experiments). Smooth muscle cells were isolated using FACS flow cytometry as described. C, levels of AT 1 R b mRNA are ß2.4-fold greater than those of AT 1 R a in mesenteric arteries from WT mice ( * P < 0.05; n = 3 separate experiments). C, levels of AT 1 R a mRNA are ß7-fold greater than those of AT 1 R b in samples from whole kidney ( * P < 0.05; n = 3 separate experiments).
lead to smooth muscle cell membrane depolarization and vasoconstriction. Our findings show that although two AT 1 R isoforms are present in cerebral arterial myocytes, only the AT 1 R b isoform was necessary for the initiation of myogenic constriction. Further, we found that stimulation of AT 1 R using mechanical stress or the endogenous peptide agonist Ang II elicited TRPM4-dependent cation currents, indicating that these two stimuli engage the same intracellular signalling pathway. We conclude that AT 1 R b is an obligatory sensor of intraluminal pressure in cerebral arteries smooth muscle cells and that engagement of this receptor initiates a signalling cascade that results in cation influx through TRPM4 channels. In a groundbreaking study, Zou and colleagues showed that AT 1 R is directly activated by mechanical stress in a manner that is independent of agonist binding (Zou et al. 2004) . The mechanosensitivity of this receptor appears to be an intrinsic property, as stretch of the plasma membrane induces an anti-clockwise rotation, shifting the seventh transmembrane domain into the ligand-binding site to initiate intracellular G q -protein-dependent signal transduction pathways (Yasuda et al. 2008) , demonstrating that cation current activity induced by Ang II (30 nM) in cerebral artery myocytes from WT (A) and AT 1 R a −/− (B) mice is attenuated by the TRPM4 inhibitor 9-phenanthrol (30 µM). * P < 0.05 vs. all other groups; n = 6-13 (WT) and 5-7 (AT 1 R a −/− ) cells per group. 3 mmHg of negative pressure was maintained at the patch pipette during these experiments. C, representative traces (left) and summary data (right), demonstrating that Ang II (30 nM)-induced vasoconstriction of pressurized cerebral arteries from WT (top) and AT 1 R a −/− (bottom) mice is attenuated by losartan (1 µM, * P < 0.05 vs. Ang II; n = 5-6 arteries per group).
J Physiol 595.14 mechanosensitivity of AT 1 R in cardiomyocytes is linked to pressure-induced cardiac hypertrophy (Zou et al. 2004) . Considering the vascular myogenic response, a slight delay between the application of stepwise increases in intraluminal pressure and the onset of vasoconstriction that is typical of such experiments, such as shown here, is consistent with a metabotropic rather than an ionotropic mechanosensory signalling mechanism. Initial insight into how mechanical activation of AT 1 R could influence smooth muscle function was reported by Mederos y Schnitzler, who showed that overexpression of cloned AT 1 R receptors conveyed stretch-induced activation of TRPC6 currents to HEK cells and the A7r5 aortic smooth muscle-derived cell line via G-protein signalling and PLC activity (Mederos y Schnitzler et al. 2008) . A contrasting study by Anfinogenova et al. reported that G q -coupled receptor agonists failed to enhance stretch-induced TRPC currents and did not augment myogenic constriction of cerebral arteries (Anfinogenova et al. 2011) , concluding that G q -coupled receptors do not enhance the mechanosensitivity of native smooth muscle cells. Two recent studies using genetic knockout models to resolve this conflict provided solid evidence that AT 1 R acts as a pressure sensor in vascular smooth muscle cells (Blodow et al. 2014; Schleifenbaum et al. 2014) . However, these studies generated additional controversy, with Schleifenbaum et al. (2014) reporting that myogenic constriction of mesenteric arteries was abolished by genetic knockout of AT 1 R a , and Blodow et al. (2014) reporting an essential role for AT 1 R b in the vascular response to pressure. Here, we found that myogenic constriction of cerebral and mesenteric arteries is independent of AT 1 R a expression and that expression of AT 1 R b is necessary for myogenic constriction of cerebral arteries. Indeed, we find that cerebral arteries from AT 1 R a −/− mice are more sensitive to intraluminal pressure compared to controls. This may be a consequence of adaptation to the chronic hypotensive phenotype reported for AT 1 R a −/− mice (Ito et al. 1995) . The reasons for these disparate findings reported here and those of Schleifenbaum et al. are unclear. The basic experimental procedures are essentially identical (Schleifenbaum et al. 2014) , and the AT 1 R a −/− mice employed by both studies were derived from the same transgenic founder strain (Ito et al. 1995) , although the former study backcrossed the AT 1 R a −/− mice in subsequent generations into a different mouse strain and genetic background (FVB/N). Resolution of this issue is important because AT 1 R is broadly expressed and influences the cardiovascular system through cardiac, renal, and central mechanisms, as well as mechanisms acting at the level of the resistance vasculature. Conclusive identification of the specific AT 1 R isoform responsible for sensing vascular pressure is necessary for the appropriate interpretation of existing studies using AT 1 R-knockout animals and the design of future experiments using knockdown approaches. Exchange of tissues and mice among laboratories reporting disparate findings could help resolve this issue.
The differential influences of AT 1 R a and AT 1 R b on vascular myogenic responsiveness are probably not attributable to inherent differences in receptor structure. AT 1 R a and AT 1 R b differ at only 23 of 359 amino acids scattered throughout the sequence and are highly homologous to the single human AT 1 R (94.4% and 92.8% homology, respectively). However, our data showed that mRNA levels of AT 1 R b are more than 30-fold higher than those of AT 1 R a in homogenates of whole cerebral arteries, and mRNA expression of AT 1 R b is 45-fold higher than AT 1 R a in native cerebral artery smooth muscle cells. We also detected slightly higher (ß2.4-fold) levels of AT 1 R b compared with AT 1 R a in homogenates of whole mesenteric arteries. Our findings are largely in agreement with Blodow et al. who also reported that AT 1 R b mRNA was more abundant than AT 1 R a mRNA in cerebral and mesenteric arteries (Blodow et al. 2014) . Thus, differential expression probably explains why AT 1 R b is the dominant isoform responsible for pressure sensing. The mechanistic basis for higher expression of AT 1 R b in smooth muscle cells is not known. AT 1 R a and AT 1 R b are encoded by separate genes located on different chromosomes (Sasamura et al. 1992) , and tissue-specific expression patterns have been reported (Kitami et al. 1992; Gasc et al. 1994; Llorens-Cortes et al. 1994; Shanmugam et al. 1994) , suggesting independent transcriptional regulation. In addition, global AT 1 R a −/− (Ito et al. 1995; Sugaya et al. 1995) and AT 1 R b −/− (Chen et al. 1997 ) knockout mice have distinctive phenotypes, providing evidence that the receptors have non-redundant physiological roles. Future studies directed at uncovering the genetic mechanism responsible for preferential expression of AT 1 R b in vascular smooth muscle cells could lead to novel insight into transcriptional regulation in this tissue.
Increases in intraluminal pressure depolarize the smooth muscle cell plasma membrane, resulting in Ca 2+ influx through voltage-dependent Ca V 1.2 L-type Ca 2+ channels and vasoconstriction (Knot & Nelson, 1998) . Although several channels, including TRPC6 (Welsh et al. 2002) , TRPM4 (Earley et al. 2004 (Earley et al. , 2007 Reading & Brayden, 2007; Gonzales et al. 2010b Gonzales et al. , 2014 Li et al. 2014) and the Ca 2+ -activated chloride channel anoctamin-1 (Ano-1) (Bulley et al. 2012) , have purported roles in pressure-induced smooth muscle cell depolarization, definitive evidence of the inherent mechanosensitivity of these channels is lacking. The current study reinforces the concept put forward by several laboratories that signal transduction pathways initiated by stretch-sensitive GPCRs, and not directly mechanosensitive ion channels, are the primary initiators of pressure-induced smooth muscle cell membrane depolarization and myogenic vasoconstriction (Blodow et al. 2014; Gonzales et al. 2014; Li et al. 2014; Schleifenbaum et al. 2014) . Our findings identify AT 1 R b as the initiator of a signalling pathway that leads to an increase in TRPM4 cation currents in response to mechanical stress of the plasma membrane. Activation of TRPM4, a Ca 2+ -activated channel selective for monovalent cations (Launay et al. 2002; Nilius et al. 2003) , in smooth muscle cells leads to Na + influx and membrane depolarization (Earley et al. 2004) . Under physiological conditions, TRPM4 channel activity is stimulated by Ca 2+ released from the SR through IP 3 receptors (Gonzales et al. 2010a; Gonzales & Earley, 2012) . A prior report from our laboratory demonstrated that this Ca 2+ signalling pathway is activated by mechanical stretch via a losartan-sensitive receptor pathway coupled to PLCγ1. The current findings now identify AT 1 R b as the primary pressure sensor within this force-sensitive signalling network.
The unique metabolic and anatomical constraints of the brain require precise control of perfusion pressure to maintain cerebral vascular homeostasis. Uncompensated drops in pressure result in hypoperfusion and loss of neurovascular coupling (Finnerty et al. 1954; Osol et al. 2002) whereas impairment of pressure-induced constriction can expose the cerebral microcirculation to elevated hydrostatic pressure, leading to capillary instability, vasogenic oedema, and hyperperfusion-induced encephalopathy (Osol et al. 2002; Pires et al. 2013) . Under in vivo conditions, arterial myocytes are constantly exposed to intraluminal pressure and circulating or locally produced Ang II. Our findings show that activation of smooth muscle cell AT 1 Rs by stretch of the plasma membrane or by Ang II engage a common intracellular pathway that leads to increased TRPM4 cation current density and vasoconstriction. These data suggest that that, under physiological conditions, AT 1 R responds to changes in intraluminal pressure and localized Ang II levels in an additive fashion to regulate smooth muscle cell membrane potential and contractility. Polymodal activation of AT 1 R by pressure and agonist could operate in a feed-forward manner to contribute to vascular pathologies, such as smooth muscle hypertrophy and hyperplasia, that occur during hypertension associated with elevated Ang II levels (Griffin et al. 1991) .
In summary, our findings demonstrate that AT 1 R b is indispensable for myogenic contractility of cerebral pial arteries and that expression of AT 1 R a is not essential for this function. We also show that activation of AT 1 R by plasma membrane stretch or the peptide agonist Ang II engages a shared signalling pathway that increases TRPM4 cation current density. Identification of specific non-redundant functions of the two AT 1 R isoforms in rodents may provide critical insight into the function of this receptor in specific organ systems in humans.
